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COMMENTARY Open Access
The role of multilateral organizations and
governments in advancing social
innovation in health care delivery
Beatrice Halpaap1* , Rosanna W. Peeling2 and François Bonnici3
Abstract
Background: Despite great medical advances and scientific progress over the past century, one billion people
globally still lack access to basic health care services. In the context of the 2030 Agenda for Sustainable
Development social innovation models aim to provide effective solutions that bridge the health care delivery gap,
address equity and create social value. This commentary highlights the roles of multilateral organizations and
governments in creating an enabling environment where social innovations can more effectively integrate into
health systems to maximize their impact on beneficiaries.
Main text: The integration of social innovations into health systems is essential to ensure their sustainability and
the wide dissemination of their impact. Effective partnerships, strong engagement with and endorsement by
governments and communities, regulations, trust and sometimes willingness are key factors to enhance system
integration, replication and dissemination of the models. Three examples of social innovations selected by the
Social Innovation in Health Initiative illustrate the importance of engaging with governments and communities in
order to link, integrate and synergize their efforts. Key challenges that they encountered, and lessons learnt are
highlighted. Multilateral organizations and governments increasingly engage in promoting and supporting the
development, testing and dissemination of social innovations to address the health care delivery gap. They play an
important role in creating an enabling environment. This includes promoting the concept of social innovation in
health care delivery, spreading social innovation approach and lessons learnt, fostering partnerships and leveraging
resources, convening communities, health system actors and various stakeholders to work together across
disciplines and sectors, and nurturing capacity in countries.
Conclusions: Multilateral organizations and local and national governments have a critical role to play in creating
an enabling environment where social innovations can flourish. In supporting and disseminating social innovation
approach, multilateral organizations and governments have a great opportunity to accelerate Universal Health
Coverage and the achievement of the Sustainable Development Goals.
Keywords: Social innovation, Health care delivery, Community engagement, Multidisciplinary research, Multilateral
organizations, Government engagement
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Background
Despite great medical advances and scientific progress
over the past century, one billion people globally still
lack access to basic health care services. Research and
development efforts on developing novel technologies,
medicines, vaccines and diagnostics have failed to reach
many populations, in particular those marginalized and
in greatest need. “Leaving no one behind” is at the core
of the 2030 Agenda for Sustainable Development and of
the Sustainable Development Goals. These commitments
call for innovative approaches [1] to provide quality, ac-
cessible and affordable healthcare. Social innovation in
health models aim to provide solutions that enhance ap-
proaches to implementing health care programmes to
bridge the health care delivery gap, address equity and cre-
ate social value. This commentary highlights the role of
multilateral organizations and governments in creating an
enabling environment where social innovations can more
effectively integrate within health systems to maximize
their impact for beneficiaries. It presents three examples
of social innovations illustrating the importance of en-
gaging with governments and communities to link, inte-
grate and synergize their efforts, some of the challenges
encountered and lessons learnt.
Main text
Innovative solutions to improve health systems
Social innovation, as defined by Phills and co-authors, is
“the process of inventing, securing support for, and
implementing novel solutions to social needs and prob-
lems” [2]. As applied to healthcare access and coverage,
the aim is to ensure that health systems and services are
available to all people, including the most vulnerable
and hard-to-reach populations. The integration of inno-
vations into health systems is essential to ensure the sus-
tainability and wide-spread dissemination of their impact
[2]. Health systems include communities and actors from
the public, private and civil society sectors. As highlighted
in the 2030 Agenda for Sustainable Development [1],
there is a need to break down boundaries between the dif-
ferent sectors to facilitate new interactions, build partner-
ships among the various health system actors, and foster
the strong engagement of different communities. Lack of
partnerships, engagement, endorsement, regulations, trust
and sometimes willingness may prevent innovations from
being replicated and disseminated. Social innovations offer
a model to address this silo approach and promote an in-
clusive process engaging communities [3] and various
health actors to work together to identify problems and
develop and implement innovative solutions. They focus
on the people they serve rather than on diseases, and pro-
mote multidisciplinary approaches and collaborations be-
tween various sectors.
Learning from social innovations in low- and middle-
income countries
Examples of social innovations in health exist in many
parts of the world, even if these are not always identified
as such. However, evidence of what works, what does
not work, and lessons learnt, in particular in low- and
middle-income countries, is not systematically collected,
shared and discussed. Research is needed to better
understand the factors involved in the feasibility, effect-
iveness and sustainability of innovations. Research is also
needed for these innovations to achieve a wider impact,
through better comprehending and describing the mech-
anisms for replication, potential scalability and dissemin-
ation [4].
In 2014 the Social Innovation in Health Initiative
(SIHI) was established as a collaboration between TDR
(the Special Programme for Research and Training in
Tropical Diseases), the Bertha Centre for Social Innovation
and Entrepreneurship at the University of Cape Town
Graduate School of Business, the Skoll Centre for Social
Entrepreneurship at Oxford University, and the London
School of Hygiene and Tropical Medicine. The initiative
aims to advance community-engaged social innovation in
health within low- and middle-income countries, through
fostering research, building capacity, and undertaking advo-
cacy towards greater health equity through system integra-
tion. In 2016, the network expanded to engage low- and
middle-income countries to establish SIHI country hubs
through collaboration with Makerere University in Uganda,
the University of Malawi, the University of the Philippines,
and later, the Centro Internacional de Entrenamiento e
Investigaciones Médicas in Colombia and the Social
Entrepreneurship to Spur Health in China. These hubs pro-
mote the concept of social innovation and provide a plat-
form to convene the various health system actors to
identify problems and develop solutions. They foster re-
search on social innovation and help to strengthen research
capacity. The initiative also supports social innovations by
strengthening the capacity of these organizations to sustain
and replicate themselves, enhance cross-sectoral partner-
ships, and conduct research on how best to engage with
governments. In addition, SIHI collaborates with various
organizations advancing innovation in health and contrib-
uting to SIHI’s mission [5].
A first step for the Social Innovation in Health Initiative
in 2015 was to identify and study selected cases of social
innovations which were addressing health care delivery
and had been operational for at least a year in a low- or
middle-income country. Following an open call, 179
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nominations were received and 23 cases across 15 coun-
tries were selected by an expert review panel. Selection
criteria included appropriateness of the solution, degree of
innovativeness, inclusiveness, affordability, effectiveness,
scalability and sustainability. Research on these innova-
tions was conducted to better understand how they had
been developed and implemented, the opportunities and
challenges they faced in delivering their services and in
making and measuring their impact, the factors involved
in their sustainability and potential scalability, and the
main lessons learnt [6, 7].
The innovations studied used various types of business
models to run their respective operations. The three ex-
amples described below highlight the importance of
strong engagement with governments and health sys-
tems actors to sustain and replicate the impact of these
organizations.
Sproxil, Inc. is a for-profit company established in
2009 and initially operating in Nigeria to build trust
across supply chains of pharmaceutical products. The
company provides a unique labelling system, combined
with technology to identify counterfeit medicine at the
point of purchase. The technology also enables data col-
lection on counterfeit products, providing valuable
insight for regulatory authorities and manufacturers.
Sproxil, Inc. only charges manufacturers, who pay into
the system for their products to be protected. However,
it also receives donor grants to enable expansion in new
countries. Within the first six years, Sproxil, Inc. had ex-
panded from Nigeria to Ghana, India, Kenya, Pakistan
and the United Republic of Tanzania, and registered
more than 20 million authentications, with 12 million
unique users of pharmaceutical products. The company
turned profitable in 2014. One key element to sustain
and replicate this model is endorsement from regulatory
authorities. This enhances the confidence of both manu-
facturers and consumers and provides countries with
critical data to protect against counterfeit products and
to strengthen the supply chain. Challenges to expand in-
clude: (i) lack of mobile phone penetration and a reliable
telecommunication network; (ii) level of engagement
with government and regulatory authorities; and (iii)
poor awareness of consumers of counterfeit products
and their danger [6, 7].
A second example is One Family Health, a public-pri-
vate community partnership in Rwanda. A foundation
was established in 2012 in the United Kingdom of Great
Britain and Northern Ireland in order to enhance access
to essential primary care services for people living in
mountainous rural areas of Rwanda. In partnership with
the Rwandan Ministry of Health and an operating agree-
ment with district level health departments, One Family
Health established a limited liability low profit company
to run franchised nurse-owned health posts. These
private providers are integrated in the health system and
leverage the national health insurance scheme to deliver
sustainable care. As partners, the Ministry of Health
and, when required, the community provide the land
and infrastructure for health posts to be established. The
health posts are financed by fees for service, while the
One Family Health Foundation is financed through fran-
chise royalty fees, marketing and pharmaceutical product
sales. Within the first three years, One Family Health
had opened more than 90 health posts which served
more than 500 000 patients across 11 districts in
Rwanda. The partnerships with government, community
and other health system actors are key elements in the
significant and sustainable impact of this approach and
in the possibility of replicating the model in other
African countries. Challenges that limit the speed of
expansion include: (i) the need to ensure that health
system actors trust and support the model; (ii) the need
to invest in developing strong payment systems and op-
erating procedures; and (iii) availability of government
infrastructure in villages to establish health posts. Polit-
ical and economic stability in the country, implementa-
tion of universal health coverage, and willingness of the
government to engage in a public-private partnership
are crucial elements for replication of this model in
other countries [6, 7].
The third example is a nongovernmental organization,
using a revenue generating business model to empower
community members to become social entrepreneurs.
Living Goods Uganda was established in 2007 and
adopted good practice in entrepreneurship and perform-
ance management to deliver a community health worker
programme which has been effective in reducing under
five child mortality by 27% and neonatal mortality by
33% after three years of intervention [8]. Living Goods
provides ongoing training, access to quality medicines
and products, and performance incentives to village-
based health entrepreneurs. Through revenue generation
from product sales and franchised royalty fees, Living
Goods is able to sustain 60% of its operations. The
organization also receives unrestricted donor grants,
which are used for expanding the model through public
sector partnerships in other regions in Uganda and in
other countries. In 2013 Livings Goods considered rely-
ing solely on their revenue. Yet becoming financially
self-sustaining would have limited its scaling capacity
and the number of lives saved. The organization opted
to continue receiving donor grants to support its scale
up. Critical elements of Living Goods’ scaling strategy
are: (i) integration with the government; (ii) replication
through partnerships with other actors; and (iii) leverage
of large scale funding [6, 7].
These examples illustrate the potential value of devel-
oping not only strategies for organizational scaling-up,
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but also strategies to link and integrate the innovation
into the health system to enhance sustainability and to
create a wider impact reaching more beneficiaries. De-
veloping public-private partnerships requires effort and
time investment that might slow down the expansion of
social innovations, yet this is critical to success and sus-
tainability. These lessons confirm the findings from case
studies in the report Beyond Organizational Scale: How
Social Entrepreneurs Create Systems Change [9]. The re-
port highlights how changing systems rules can require
neutral organizations or institutions as “honest brokers.”
When looking at social impact, the choice of the busi-
ness model should be based on the dynamics of the mar-
ket and context in which the organization operates.
Partnerships between public, private and philanthropic
sectors emerged as an important factor for systemic change
and sustainable impact. Too often engagement with gov-
ernments seems to be a challenge. In the above case studies
and in most of the other case studies documented, replic-
ability and scalability of the social innovation approach in
new countries strongly depend on the government’s will-
ingness to engage in multisectoral partnerships. To support
and enhance a systems approach, a change of mindset in
approaching health care delivery is needed at various levels
of the system. The value of engaging communities and
working with experts from various disciplines and diverse
sectors needs to be promoted at the global health level in
order to create awareness and influence practices at na-
tional and local levels.
Creating an enabling environment
Building upon the lessons learnt, in 2015 the World
Health Organization made a call for global action to em-
brace and adopt social innovation [10]. The call invited
governments, multilateral organizations and other health
system actors to introduce innovative and effective ap-
proaches to enhance health care delivery and reach vul-
nerable populations. It promoted the value of social
innovations in health care delivery with the aim to spread
the approach in low- and middle-income countries.
Multilateral organizations and governments have a key
role to play in fostering such change and in creating an
enabling environment. They are increasingly engaged in
promoting and supporting the development, testing and
dissemination of social innovations and of their approach
to address the health care delivery gap. Special initiatives
and programmes include the Social Innovation in Health
Initiative mentioned above [11]; The Innovation for Up-
take, Scale and Equity in Immunisation programme
launched by the Global Alliance for Vaccines and Immun-
isation, the Vaccine Alliance [12]; the Innovation Facility
established at United Nations Development Programme
(UNDP) [13]; and the UNICEF Innovation Centre [14].
The WHO framework for people-centred integrated health
services provides a practical guide for social innovations. It
calls for steps to unlock the capacity of people and com-
munities to take an active role in their own health and the
health system, to reorient health services to ensure that
care is provided in the most appropriate settings, and to
coordinate care across providers, organizations, care set-
tings and beyond the health sector to include social and
other relevant services [15].
Creating an enabling environment also involves gener-
ating and fostering new knowledge to better understand
what works and what does not work, and how to sustain
their efforts and their impact. There is a need to build
capacity to integrate research in the processes of social
innovation. Social innovators, community members and
other health system actors need to engage in research to
better understand how to improve performance, how to
best engage with governments, and which factors are in-
volved in moving towards the sustainability, replicability
and scalability of their innovations as relevant.
Multilateral organizations can facilitate linkages to
governments and can catalyse, through their normative
role, the development of guidelines and standards to
support health actors to advance social innovations and
integrate research in their process. Multilateral organiza-
tions and local and national governments also have an
important role to play to help mobilize resources for in-
novations through, for example, the creation of
innovation funds (e.g. UNICEF Innovation Fund, UNDP
Innovation Facility). They draw on and provide unlim-
ited networks of experts at the global level and at the re-
gional and local country office level. These foster an
environment in which social innovations can thrive and
flourish.
Conclusions
Multilateral organizations and governments have a critical
role to play in promoting the concept of social innovation
in health care delivery, in spreading its approach, in nurt-
uring social innovation organizations and in creating an
enabling environment. They can advocate and promote
the value of social innovations at local, national and global
levels. They can actively support platforms to engage com-
munities and bring all actors to work together. They can
promote and support the integration of research in social
innovations to better understand what works and what
does not work. They can foster and build partnerships and
leverage financial or in-kind resources and support cap-
acity strengthening in countries. In supporting and dis-
seminating social innovation approach in countries,
multilateral organizations and governments have a great
opportunity to learn and become more agile and respon-
sive to accelerate Universal Health Coverage and the
achievement of the Sustainable Development Goals.
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